Dupont Capital Management Corp Amgen Inc Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $242,724 - $295,840	-1,075 Reduced 37.34%	1,804 $436,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $118,637 - $150,743	-518 Reduced 15.25%	2,879 $0
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $654,076 - $737,679	-2,914 Reduced 46.17%	3,397 $766,000
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $46,372 - $51,604	-201 Reduced 3.09%	6,311 $1.54 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $97,136 - $107,458	443 Added 7.3%	6,512 $1.58 Million
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $472,340 - $540,550	-2,375 Reduced 28.13%	6,069 $1.37 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $1.43 Million - $1.68 Million	-6,749 Reduced 44.42%	8,444 $1.8 Million
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $68,205 - $75,668	-292 Reduced 1.89%	15,193 $3.7 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $966,639 - $1.13 Million	-4,356 Reduced 21.95%	15,485 $3.85 Million
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $1.11 Million - $1.32 Million	-5,129 Reduced 20.54%	19,841 $4.56 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $18,537 - $20,615	79 Added 0.32%	24,970 $6.35 Million
Q2 2020 Jul 24, 2020	SELL	$197.81 - $242.74 $388,301 - $476,498	-1,963 Reduced 7.31%	24,891 $5.87 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $311,448 - $413,065	1,709 Added 6.8%	26,854 $5.44 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $2.85 Million - $3.67 Million	-15,076 Reduced 37.48%	25,145 $6.06 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $2.1 Million - $2.51 Million	-12,042 Reduced 23.04%	40,221 $7.78 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $597,452 - $700,349	-3,584 Reduced 6.42%	52,263 $9.63 Million
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $949,748 - $1.07 Million	-5,251 Reduced 8.59%	55,847 $10.6 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $597,640 - $697,637	-3,350 Reduced 5.2%	61,098 $11.9 Million
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $55,772 - $62,875	-301 Reduced 0.46%	64,448 $13.4 Million
Q2 2018 Jul 30, 2018	BUY	$166.05 - $186.51 $109,094 - $122,537	657 Added 1.03%	64,749 $12 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $490,669 - $573,408	-2,896 Reduced 4.32%	64,092 $10.9 Million
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $12.1 Million - $13.5 Million	-71,798 Reduced 51.73%	66,988 $11.6 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $23.2 Million - $26.5 Million	138,786	138,786 $25.9 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account